本文由小咖机器人翻译整理

期刊来源：Ann Intern Med

原文链接：https://doi.org/10.7326/M24-0605

摘要内容如下：

这篇文章重点介绍了2023年发表的一系列重要的肾脏学研究，这些研究与非肾脏科医生有关。四项研究调查了慢性肾脏疾病或心血管疾病的进展与使用非那酮、补充镁、铁标记物和COVID-19的关系。两项研究调查了改善慢性肾脏疾病管理的具体方面的治疗方法，包括治疗贫血的Daprodustat和治疗高磷血症的Patiromer。一项研究表明，在髓袢利尿剂中加入乙酰唑胺可增加急性失代偿性心力衰竭患者的利尿作用，并可广泛影响肾功能。另一项研究发现，每天服用一次氢氯噻嗪并不能预防肾结石复发。最后，抗生素管理干预安全地减少了体弱老年人疑似尿路感染的抗生素处方。

英文原文如下：

Abstracts

This article highlights a selection of important nephrology studies published in 2023 that have relevance for nonnephrologist physicians. Four studies examined progression of chronic kidney disease or cardiovascular disease with respect to finerenone use, magnesium supplementation, iron markers, and COVID-19. Two studies examined treatments to improve specific aspects of chronic kidney disease management, including daprodustat to address anemia and patiromer to address hyperphosphatemia. One study showed that acetazolamide added to loop diuretics increased diuresis in acute decompensated heart failure across a wide range of renal function. Another study found that once-daily hydrochlorothiazide did not prevent kidney stone recurrence. Finally, an antibiotic stewardship intervention safely reduced antibiotic prescribing for suspected urinary tract infection in frail older adults.

-----------分割线---------

点击链接：https://www.mediecogroup.com/community/user/vip/categories/ ，成为医咖会员，获取12项专属权益。